This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gallbladder removal, or cholecystectomy, is a surgical procedure that removes the gallbladder from the body. The gallbladder is a small organ located in the upper right abdomen that stores bile, a fluid that helps the digestive process. The procedure is usually done to treat gallstones, which are hardened deposits of bile that can form in the gallbladder and cause severe abdominal pain. Gallbladder removal is a relatively common procedure and usually has a low risk of complications. However, there are some potential risks and side effects associated with the procedure. These include infection, bleeding, and damage to the bile ducts. The most common long-term side effect of gallbladder removal is diarrhea. This occurs because the bile that was stored in the gallbladder is no longer available to help digest fatty foods. Without bile, the intestines are unable to break down fats, which can lead to excess water in the stool, resulting in diarrhoea. Other potential long-term consequences of gallbladder removal include weight gain, malnutrition, and an increased risk of developing gallstones in other organs, such as the liver. Gallbladder removal may also cause changes in the way the body absorbs and processes certain medications. If a patient is taking any medications, the doctor should be consulted before and after the surgery to ensure that the medications are still working properly. In most cases, gallbladder removal is a safe and relatively straightforward procedure that can provide relief from gallstones and abdominal pain.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States